Open Access

New clinical outcomes of Fimasartan

Event: ESC Congress 2022
Topic: Hypertension
Session type: Satellite Symposium
Sponsored by Boryung
Date: 26 August 2022
Time: 10:15 - 11:00

Congress Session

This content is currently on OPEN ACCESS

Sign in to view the resources

4 presentations in this session

New clinical outcome of Fimasartan in the elderly and diabetic chronic kidney disease.

Speaker: Doctor S. Park (Incheon, KR)
Thumbnail

Fimasartan-based blood pressure control after acute cerebral ischemia: FABULOUS Study.

Speaker: Associate Professor W. Lee (Seongnam, KR)
Thumbnail

Efficacy, safety and clinical experience of Fimasartan in Mexican patients with essential hypertension.

Speaker: Doctor A. Pavia Lopez (Mexico City, MX)
Thumbnail

Conclusion.

Speaker: Professor I. Chae (Seoul, KR)
Speaker: Professor S. Kim (Seoul, KR)
Thumbnail

5 speakers from this session

Doctor Sang-Don Park

Inha University Hospital, Incheon (Korea (Republic of))
2 presentations
0 follower

Associate Professor Wonjae Lee

Seoul National University Bundang Hospital, Seongnam (Korea (Republic of))
1 presentation
0 follower

Doctor Abel Alberto Pavia Lopez

American British Cowdray Medical Center, Mexico City (Mexico)
1 presentation
0 follower

Professor In-Ho Chae

Seoul National University Hospital, Seoul (Korea (Republic of))
1 presentation
0 follower

Professor Sang-Hyun Kim

Boramae Hospital, Seoul (Korea (Republic of))
2 presentations
0 follower

This platform is supported by

logo Novo Nordisk